Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 21% ± 4% | |
| epithelial cell | 4 studies | 31% ± 6% | |
| monocyte | 4 studies | 21% ± 8% | |
| retinal rod cell | 3 studies | 23% ± 7% | |
| glutamatergic neuron | 3 studies | 36% ± 14% | |
| alveolar macrophage | 3 studies | 23% ± 5% | |
| interneuron | 3 studies | 36% ± 18% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 28% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 401.81 | 89 / 89 | 99% | 4.46 | 891 / 901 |
| thymus | 100% | 604.97 | 653 / 653 | 98% | 4.56 | 595 / 605 |
| breast | 100% | 612.52 | 459 / 459 | 97% | 11.31 | 1089 / 1118 |
| brain | 98% | 399.70 | 2587 / 2642 | 99% | 3.83 | 700 / 705 |
| skin | 100% | 478.66 | 1809 / 1809 | 97% | 6.43 | 458 / 472 |
| prostate | 100% | 311.51 | 244 / 245 | 92% | 2.92 | 461 / 502 |
| lung | 100% | 418.29 | 576 / 578 | 91% | 2.58 | 1056 / 1155 |
| ovary | 100% | 569.67 | 180 / 180 | 91% | 3.06 | 391 / 430 |
| adrenal gland | 100% | 661.36 | 258 / 258 | 87% | 3.67 | 199 / 230 |
| esophagus | 100% | 342.45 | 1445 / 1445 | 85% | 2.13 | 155 / 183 |
| pancreas | 92% | 203.28 | 301 / 328 | 89% | 2.25 | 159 / 178 |
| uterus | 100% | 409.93 | 170 / 170 | 80% | 2.19 | 368 / 459 |
| intestine | 100% | 319.00 | 965 / 966 | 80% | 1.82 | 422 / 527 |
| stomach | 100% | 320.31 | 359 / 359 | 79% | 1.77 | 227 / 286 |
| bladder | 100% | 241.33 | 21 / 21 | 75% | 1.65 | 379 / 504 |
| liver | 95% | 192.61 | 215 / 226 | 59% | 1.25 | 240 / 406 |
| eye | 0% | 0 | 0 / 0 | 100% | 10.78 | 80 / 80 |
| spleen | 100% | 517.62 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 393.29 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 407.71 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 100% | 795.76 | 925 / 929 | 0% | 0 | 0 / 0 |
| heart | 98% | 408.79 | 840 / 861 | 0% | 0 | 0 / 0 |
| muscle | 98% | 321.07 | 783 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 3.00 | 28 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 2.62 | 43 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006790 | Biological process | sulfur compound metabolic process |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005764 | Cellular component | lysosome |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0004065 | Molecular function | arylsulfatase activity |
| GO_0033889 | Molecular function | N-sulfoglucosamine-3-sulfatase activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ARSG |
| Protein name | Arylsulfatase G Arylsulfatase G (ASG) (EC 3.1.6.1) (N-sulfoglucosamine-3-sulfatase) (EC 3.1.6.15) |
| Synonyms | UNQ839/PRO1777 KIAA1001 |
| Description | FUNCTION: Displays arylsulfatase activity at acidic pH towards artificial substrates, such as p-nitrocatechol sulfate and also, but with a lower activity towards p-nitrophenyl sulfate and 4-methylumbelliferyl sulfate . Catalyzes the hydrolysis of the 3-sulfate groups of the N-sulfo-D-glucosamine 3-O-sulfate units of heparin . . |
| Accessions | J9JIG6 Q96EG1 ENST00000448504.6 ENST00000621439.5 ENST00000452479.6 |
